Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

December 5, 2022

EMA validates GSK’s application for myelofibrosis therapy

The European Medicines Agency (EMA) has validated GSK’s marketing authorization application (MAA) for momelotinib to treat myelofibrosis.

EMA validates GSK’s application for myelofibrosis therapy